Waterloo Zantac Attorney
Filing a Zantac Lawsuit
Recent reports have revealed a link between ranitidine—commonly referred to by its trade name, Zantac—and several different types of cancer. Ranitidine is a popular antacid medication used to reduce heartburn and upset stomach. However, prolonged use of ranitidine has been connected with bladder cancer, stomach cancer, pancreatic cancer, and brain cancer, among others.
If you or a loved one took Zantac, or any ranitidine-containing antacid medication, and later developed cancer, you could be entitled to financial compensation. Ball, Kirk & Holm, P.C. is currently accepting Zantac lawsuits in Waterloo and behalf of clients throughout the state of Iowa. If you believe you may be eligible to take part in a lawsuit or mass tort, reach out to us right away.
Call (319) 220-0416 or submit an online contact form to request a free, no-obligation consultation. We have offices in Waterloo and Iowa City, and serve the entire state.
The FDA Warns of Cancer Risk Linked to Zantac & Other Ranitidine Medications
In September of 2019, the Food and Drug Administration (FDA) issued an advisory after reports revealed that a carcinogenic contaminant known as NDMA (n-nitrosodimethylamine) was found to be present in ranitidine at levels ranging between 3,000 to as much as 26,000 times higher than acceptable FDA standards.
Ranitidine is the active ingredient in Zantac and many other over-the-counter (OTC) and prescription antacid medications. According to various Zantac lawsuits, a single 150mG Zantac pill contains in excess of 2.5 million ng of NDMA; the FDA’s acceptable limit is below 100 ng. According to these same lawsuits, the manufacturers of Zantac (Sanofi and Boehringer Ingleham), as well as other ranitidine manufacturers, knew of the risks associated with NDMA levels in ranitidine yet did nothing to warn consumers.
Types of Cancer Associated with Zantac
NDMA is a naturally occurring substance and a known carcinogen. The high level of NDMA in ranitidine, the active ingredient in Zantac, has been linked to the development of a range of cancers.
To date, studies have linked Zantac/ranitidine and the following types of cancer:
- Bladder cancer
- Pancreatic cancer
- Stomach cancer
- Brain cancer
- Breast cancer
- Kidney cancer
- Liver cancer
- Intestinal cancer
- Prostate cancer
- Testicular cancer
- Colorectal cancer
- Esophageal cancer
- Non-Hodgkin’s lymphoma
Please note that this is not an exhaustive list; continuous studies show that Zantac/ranitidine may be linked to multiple other forms of cancer.
Who Can File a Zantac Lawsuit?
In order to be eligible to seek financial compensation, you must prove that you developed cancer as a result of taking Zantac or another ranitidine-containing medication. This can be extremely complex, as cancer is one of the most common illnesses in the United States and showing that you would not have otherwise had cancer if you did not take Zantac can be difficult. It is absolutely essential that you work with an experienced attorney who can investigate your claim and build a strong case on your behalf.
Your attorney will work to show that you:
- Took Zantac or another ranitidine medication, typically over a prolonged period of time
- You were diagnosed with some form of cancer
- Your cancer was a direct result of you taking Zantac/ranitidine medications
- You sustained measurable damages
Depending on the specifics of your situation, your damages may include things like medical bills and lost wages, future lost earnings and medical expenses, pain and suffering, or wrongful death damages in the event that your loved one died as a result of Zantac-related cancer.
If you believe that you or a loved one developed cancer as a result of taking Zantac or some other ranitidine-containing antacid medication, get in touch with our firm right away. Our Waterloo Zantac lawsuit lawyers can help you understand your rights and determine if you have grounds for a claim. We can also inform you of your various options, including filing a lawsuit or taking part in a mass tort, and the potential benefits of each option.